颈动脉海绵窦瘘(CCF)是病理性的,颈动脉和海绵窦之间的动静脉通信。它们通过分流动脉血流入静脉系统而引起各种复杂的神经眼科症状。在这项研究中,我们对与CCF相关的神经眼科表现进行了系统评价.在系统评价期间,遵循了2020年系统评价和荟萃分析指南的首选报告项目。我们搜索了PubMed,Scopus,和WebofScience从成立到2023年12月31日。用英语撰写的关于确诊CCF的患者报告临床特征的文章,诊断方式,治疗方法,结果包括在内。抽象数据包括人口统计,临床表现,静脉血流动力学,外伤史,调查方法,治疗方法,和结果。总的来说,包括33项研究,总人数为403名患者。直接CCF患者的平均年龄为42.99岁,间接CCF患者为55.88岁。在直接CCF的男性患者中观察到了优势,占51.56%,而女性在间接CCF患者中占主导地位,56.44%。所有CCF患者的临床症状均为眼球突出58例(14.39%),结膜充血29例(7.20%),复视9例(2.23%),四名患者视力模糊(0.99%),5例患者眼睑肿胀(1.24%),三名患者的眼部疼痛(0.74%),一名患者的上眼睑质量(0.25%)。血管内治疗,包括线圈和Onyx栓塞,已有效缓解临床症状并阻止这些症状的进展。总之,CCF的常见临床特征通常会突出,拥塞,和复视,有必要进行全面的神经眼科检查。及时识别视力模糊的症状对于避免永久性损伤至关重要。眼睑肿胀,眼痛,和上眼睑质量不太常见,但对于全面评估同样重要。识别这些变量不仅对于及时干预而且对于改善患者预后至关重要。因此强调了临床医生意识在管理CCF病例中的作用。
Carotid-cavernous fistulas (CCFs) are pathologic, arteriovenous communications between the carotid artery and cavernous sinus. They cause various complex neuro-ophthalmic symptoms by shunting the flow of arterial blood into the venous system. In this study, a systematic review is conducted on the neuro-ophthalmic presentations associated with CCFs. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines were followed during the systematic review. We searched PubMed, Scopus, and Web of Science from inception to December 31, 2023. Articles written in English on patients with confirmed CCFs reporting clinical features, diagnostic modalities, treatment approaches, and outcomes were included. Abstracted data included demography, clinical presentations, venous flow dynamics, trauma history, investigative methodology, approaches to treatment, and outcomes. Overall, 33 studies with a total number of 403 patients were included. The mean age at presentation was 42.99 years for patients with direct CCFs and 55.88 years for those with indirect CCFs. Preponderance was observed in male patients with direct CCFs, constituting 51.56%, while females predominated in those with indirect CCFs, at 56.44%. The clinical symptoms in all patients with CCFs were proptosis in 58 cases (14.39%), conjunctival congestion in 29 patients (7.20%), diplopia in nine patients (2.23%), vision blurring in four patients (0.99%), eyelid swelling in five patients (1.24%), pain in the eye in three patients (0.74%), and an upper lid mass in one patient (0.25%). Endovascular treatments, including coil and Onyx embolization, have been effective in relieving clinical symptoms and arresting the progression of these symptoms. In conclusion, the common clinical features in CCFs usually underline proptosis, congestion, and diplopia, necessitating a comprehensive neuro-ophthalmological review. Prompt identification of the symptoms of blurred vision is crucial to avoid permanent damage. Lid swelling, ocular pain, and an upper lid mass are less common but equally essential presentations for comprehensive evaluation. The recognition of these variable presentations is essential not only for timely intervention but also for the improvement in patient outcomes, thus emphasizing the role of clinician awareness in managing CCF cases.